Case 1:15-cv-01980-GHW Document 94-1 Filed 08/02/16 Page 2 ... · Lemke, Melissa Mota, and Kristine...
Transcript of Case 1:15-cv-01980-GHW Document 94-1 Filed 08/02/16 Page 2 ... · Lemke, Melissa Mota, and Kristine...
Case 1:15-cv-01980-GHW Document 94-1 Filed 08/02/16 Page 2 of 24
Case 1:15-cv-01980-GHW Document 94-1 Filed 08/02/16 Page 3 of 24
Case 1:15-cv-01980-GHW Document 94-1 Filed 08/02/16 Page 4 of 24
Case 1:15-cv-01980-GHW Document 94-1 Filed 08/02/16 Page 5 of 24
Case 1:15-cv-01980-GHW Document 94-1 Filed 08/02/16 Page 6 of 24
Case 1:15-cv-01980-GHW Document 94-1 Filed 08/02/16 Page 7 of 24
Case 1:15-cv-01980-GHW Document 94-1 Filed 08/02/16 Page 8 of 24
Case 1:15-cv-01980-GHW Document 94-1 Filed 08/02/16 Page 9 of 24
Exhibit B
Case 1:15-cv-01980-GHW Document 94-1 Filed 08/02/16 Page 10 of 24
Page 1 of 8
UNITED STATES DISTRICT COURT
FOR THE SOUTHERN DISTRICT OF NEW YORK
SUSAN ORR et al.,
PLAINTIFFS,
Case No. 15-CV-1980 (GHW)
-- against --
NOVARTIS CORPORATION and
ALCON LABORATORIES, INC.,
DEFENDANTS.
NOTICE OF PENDENCY OF PROPOSED CLASS ACTION AND
COLLECTIVE ACTION SETTLEMENT
TO: All women who are or were employees of ALCON LABORATORIES, INC. who held any
DIRECTOR-LEVEL, MANAGER-LEVEL, SPECIALIST/ ANALYST-LEVEL, or SALES
POSITION (as defined in this Notice) in the United States for at least one month from March 17,
2012 through November 12, 2015, excluding individuals who previously released their claims.
This Notice provides notice of a pending gender discrimination class action and collective action lawsuit,
describes a proposed settlement of this case (the “Settlement”), identifies the Settlement Classes and Collectives
certified by the Court (the “Settlement Classes”), and explains your legal rights, including what benefits are
available, who is eligible for them, and how to get them.
PLEASE READ THIS NOTICE CAREFULLY AND IN ITS ENTIRETY.
YOU MAY BE ENTITLED TO RECEIVE MONEY FROM THE SETTLEMENT.
THIS SETTLEMENT MAY AFFECT YOUR RIGHTS.
SUMMARY OF INFORMATION PROVIDED IN THIS NOTICE
1. Overview of This Lawsuit .................................................................................................................... 2
2. Who Is Eligible to Participate in the Settlement? ............................................................................ 2
3. Why Did I Receive This Notice? (This Includes Data that Alcon Provided about Your Employment.) 4
4. How Will the Settlement Fund Be Distributed? .................................................................................... 4 5. What Are My Legal Rights and Options in This Settlement, and
What Are the Important Deadlines for This Settlement? ................................................................5 6. How Will My Settlement Award Be Calculated? ..................................................................................6
7. How Will My Settlement Award Be Reported for Tax Purposes? .........................................................6
8. What Claims Am I Releasing as Part of This Settlement? .....................................................................6
9. Do I Have a Lawyer in This Case? ........................................................................................................7
10. How Will The Lawyers Be Paid?...........................................................................................................7
11. Will Certain Plaintiffs Receive Any Additional Award for Bringing and Litigating This Case on
Behalf of the Settlement Class Members? ......................................................................................7
12. When and Where Will The Court Decide Whether to Approve the Settlement? ....................................8
13. How Can I Find Out More Information about the Settlement? ..............................................................8
Case 1:15-cv-01980-GHW Document 94-1 Filed 08/02/16 Page 11 of 24
Page 2 of 8
1. Overview of This Lawsuit
This case alleges that Alcon Laboratories, Inc. (“Alcon”) and Novartis Corporation (collectively, “Defendants”)
engaged in gender-based discrimination in pay, promotion, and assignments to jobs, compensation grades, and
compensation bands against female employees who held Director-Level, Manager-Level, Specialist/Analyst-
Level, or Sales Positions at Alcon in the United States for at least one month from March 17, 2012 through
November 12, 2015. Defendants deny these allegations.
The lawsuit is known as Orr et al. v. Novartis Corporation and Alcon Laboratories, Inc., Case No. 1:15-cv-
01980-GHW, and is pending in the United States District Court for the Southern District of New York (“Civil
Action”). The case is brought as a class action and collective action lawsuit. There are thirteen plaintiffs who
have brought this case on behalf of the Settlement Classes and Collectives described in Section 2 of this Notice
and serve as Class Representatives and Collective Action Representatives on behalf of these Settlement Classes
and Collectives. The Class Representatives and Collective Action Representatives are represented by the law
firm of Sanford Heisler, LLP (“Class Counsel”).
In order to resolve the difference between the parties and avoid the risks and uncertainties of future litigation,
the Class Representatives, Collective Action Representatives, and Defendants have agreed to settle the class
action and collective action claims in this case, subject to the approval of the Court. The Settlement requires
Alcon to pay a Total Settlement Amount of $8 million to settle these class action and collective action claims.
Based on all the facts and circumstances, the Class Representatives, Collective Action Representatives, and
Class Counsel have concluded that the terms of the proposed Settlement are fair, reasonable, adequate, and in
the best interests of the Settlement Classes. In reaching this conclusion, Class Counsel has analyzed the benefits
of the Settlement and the risk of an unfavorable outcome, as well as the expense and length of continued
proceedings necessary to prosecute this action.
Defendants deny any liability or wrongdoing of any kind associated with the claims alleged in this lawsuit, and
this Settlement is in no way an admission by Defendants that they engaged in any unlawful behavior. Defendants
maintain that they have acted lawfully at all times. Defendants have agreed to these Settlement terms because
they wish to avoid further costly, disruptive, and time-consuming litigation, and desire to obtain complete and
final settlement of the claims of the Settlement Class Members.
2. Who Is Eligible to Participate in the Settlement?
This case involves four Classes of female employees at Alcon: the Director Class, the Manager Class, the
Specialist/Analyst Class, and the Sales Class. This case also involves four Collectives of female employees
at Alcon: the Director Collective, the Manager Collective, the Specialist/Analyst Collective, and the Sales
Collective. It is possible to be a member of more than one Class and more than one Collective.
1. The Director Class and the Director Collective consist of all female employees who held a Director-
Level Position at Alcon in the United States for at least one month from March 17, 2012 through
November 12, 2015, excluding individuals who entered into individual agreements with Alcon prior to
[Preliminary Approval Date] that released the Class Claims and did not contain an exception permitting
participation in this Settlement. Director-Level Positions include, but are not limited to: Assistant
Director, Associate Director, Director, Assistant Head, Associate Head, Head (excluding Vice
Presidents), Lead (when used as a noun), Global Director, U.S. Director, and Executive Director. The
Class Representatives for the Director Class are Susan Orr, Katerina Dodbiba, and Leslie Lemke. The
Collective Action Representatives for the Director Collective are Susan Orr, Katerina Dodbiba, Leslie
Lemke, Melissa Mota, and Kristine Steely.
Case 1:15-cv-01980-GHW Document 94-1 Filed 08/02/16 Page 12 of 24
Page 3 of 8
2. The Manager Class and the Manager Collective consist of all female employees who held a Manager-
Level Position at Alcon in the United States for at least one month from March 17, 2012 through
November 12, 2015, excluding individuals who entered into individual agreements with Alcon prior to
[Preliminary Approval Date] that released the Class Claims and did not contain an exception permitting
participation in this Settlement. Manager-Level Positions are non-Sales positions that include, but are
not limited to: Manager (excluding General Manager), Brand Manager, Product Manager, Finance
Manager, Financial Planning Manager, Project Manager, Project Quality Manager, Quality Assurance
Manager, Staffing Manager, Manager of Health Services and Fitness, Organizational Performance
Manager, Manager of US Exports and Accounting, Manager of Global Labeling, Manager of Global
Design, Global Labeling and Packaging Engineering Manager, Manager of Global Trade Compliance,
Integrity and Compliance Monitoring Manager, Integrity and Compliance Policy Manager, BPA and
Analysis Supporting NIBR and Chemical Research Manager, Meetings Manager, Manager of Global
Public Relations and Communications, HR Manager, HR Regional Manager, HR Business Solutions
Manager, Training Manager, and Operations Manager. Manager-Level Positions include versions of the
foregoing titles with the terms “Global,” U.S.,” “Junior,” “Senior,” Associate,” “II,” and/or “III”
appended. The Class Representative for the Manager Class, and the Collective Action Representative
for the Manager Collective, is Melinda Konczal.
3. The Specialist/Analyst Class and the Specialist/Analyst Collective consist of all female employees
who held a Specialist/Analyst-Level Position at Alcon in the United States at any time for at least one
month from March 17, 2012 through November 12, 2015, excluding individuals who entered into
individual agreements with Alcon prior to [Preliminary Approval Date] that released the Class Claims
and did not contain an exception permitting participation in this Settlement. Specialist/Analyst-Level
Positions include, but are not limited to: Talent Acquisition Specialist, Talent Management Specialist,
Recruitment Specialist, Leader Development Specialist, HR Specialist, HR Business Partner, Business
Excellence Process and Policy Specialist, Information Specialist, Logistics Analyst, Trade Compliance
Analyst, Compliance and Reporting Specialist, Accounts Payable Specialist, Accounts Payable
Coordinator, Expense Report Specialist, T&E Analyst, Documentation Analyst, Financial Systems
Analyst, Financial Analyst, Planning Analyst, Tax Analyst, Sales and Use Tax Specialist, Cost Analyst,
Accountant, Compensation Analyst, BPA Analyst, Senior BPA, Internal Control Analyst, MTO
Performance Management Analyst, Project Coordinator, Traffic Coordinator, Training Specialist,
Conference and Events Planner, Communications Specialist, Licensing Analyst, Scientist, Information
Scientist, Engineer, Safety Specialist, Animal Care Specialist, Technologist, Project Toxicologist,
Technical Specialist, and Regulatory Analyst. Specialist/Analyst-Level Positions include versions of
the foregoing titles with the terms “Global,” U.S.,” “Junior,” “Senior,” Associate,” “II,” and/or “III”
appended. The Class Representatives for the Specialist/Analyst Class are Jessicah McGaffie and
Kathryn Hoffman. The Collective Action Representatives for the Specialist/Analyst Collective are
Jessicah McGaffie, Kathryn Hoffman, and Ann-Marie Hammond.
4. The Sales Class and the Sales Collective consist of all female employees who held a Sales Position at
Alcon in the United States for at least one month from March 17, 2012 through November 12, 2015,
excluding individuals who entered into individual agreements with Alcon prior to [Preliminary
Approval Date] that released the Class Claims and did not contain an exception permitting participation
in this Settlement. Sales Positions include, but are not limited to: Medical Sales Representative, Medical
Device Sales Representative, Ocular Surface Representative, Vision Care Sales Representative,
Glaucoma Specialty Sales Representative, Glaucoma Account Manager, Allergy and Otolaryngology
Representative, Specialty Sales Representative, Surgical Hospital Account Manager, Group Hospital
Accounts Manager, Hospital Account Manager, Cataract Account Manager, Cataract Refractive
Manager, Cataract Equipment Manager, Cataract Sales Division Manager, Laser Refractive Manager,
Key Account Manager, Refractive Sales Division Manager, Refractive Equipment Manager, Refractive
Account Manager, Vitreoretinal Sales Division Manager, and Vitreoretinal Manager. Sales Positions
Case 1:15-cv-01980-GHW Document 94-1 Filed 08/02/16 Page 13 of 24
Page 4 of 8
include versions of the foregoing titles with the terms “Global,” U.S.,” “Junior,” “Senior,” Associate,”
“II,” and/or “III” appended. The Class Representatives for the Sales Class, and the Collective Action
Representatives for the Sales Collective, are Caroline Bucci, Anya Gau, Gina Giuriceo, and Jennifer
Maynard.
3. Why Did I Receive This Notice?
You have received this Notice because Alcon’s payroll records indicate that you, [NAME], were employed in
the following Director-Level, Manager-Level, Specialist/Analyst-Level, and/or Sales Positions at Alcon in the
United States for at least one month from March 17, 2012 through November 12, 2015, and therefore are a
Settlement Class Member of the following Settlement Class[es] and Collective[s] in the proposed Settlement of
this lawsuit:
[TITLE] from DATE to DATE, corresponding to the [TYPE] Class.
[TITLE] from DATE to DATE, corresponding to the [TYPE] Class.
Alcon’s records indicate that when you held [this/these] position[s] during the period from March 17, 2012
through November 12, 2015, you received the following regular earnings, short-term incentive compensation,
and long-term incentive compensation:
In [YEAR], your regular earnings were [$XX] per year, and for your work that year you
received [$XX] in short-term incentive compensation and long-term incentive compensation
valued at [$XX] as of its grant date.
In [YEAR], your regular earnings were [$XX] per year, and for your work that year you
received no short-term incentive compensation and no long-term incentive compensation.
4. How Will the Settlement Fund Be Distributed?
Alcon will pay a Total Settlement Amount of $8 million.
The Total Settlement Amount includes funds to pay attorneys’ fees and expenses to Class Counsel, Service
Payments to the Class Representatives and Collective Action Representatives, and the fees and costs of
settlement administration to the Claims Administrator. These payments are subject to Court approval; if the
Court awards payments that are lower than the amounts requested, the difference will be paid to non-profit
organizations selected by Class Counsel.
After attorneys’ fees, expenses, service payments, and settlement administration costs have been paid from the
Total Settlement Amount, the remaining funds (known as the “Class Monetary Awards Settlement Fund”) will
be paid to the Settlement Class Members as follows: (1) 85% of the Class Monetary Awards Settlement Fund
will be reserved to make Base Payments to Settlement Class Members, and (2) 15% of the Class Monetary
Awards Settlement Fund will be reserved to make Supplemental Payments to Settlement Class Members.
All Settlement Class Members will automatically receive a Base Payment without having to take any action
whatsoever. In addition, Settlement Class Members will be eligible to receive a Supplemental Payment if they
allege that, at any time from March 17, 2012, through November 12, 2015, they were discriminated against
based on their gender in seeking a promotion or in assignment to a job, compensation grade, and/or compensation
band and if they take the affirmative steps described in Section 5 below.
Case 1:15-cv-01980-GHW Document 94-1 Filed 08/02/16 Page 14 of 24
Page 5 of 8
5. What Are My Legal Rights and Options in This Settlement, and What Are the Important
Deadlines for This Settlement?
To Remain a Settlement Class Member and Receive a Base Payment: You do not have to do anything.
All Settlement Class Members are automatically entitled to a Base Payment. If you do nothing, you will remain
part of the Settlement, you will receive a Base Payment check, and you will be bound by the terms of the
Settlement. You must cash your Base Payment check within 6 months after it is issued or it will become void.
To Be Eligible for a Supplemental Payment for Alleged Gender Discrimination in Promotions or in
Assignments: To be eligible to receive a Supplemental Payment (in addition to your Base Payment), you must
complete the attached Notice of Intent to Submit Claim Form and send it to the Claims Administrator with a
postmark of no later than [30 days after Notice is mailed]. In addition, after the Court grants final approval of
the Settlement, you must submit a timely, complete, and responsive Claim Form alleging that you were
discriminated against on account of your gender in promotion or in assignment to a job, compensation grade, or
compensation band. After the Court grants final approval of the Settlement, a copy of that Claim Form, along
with instructions and deadlines for completing the form, will be mailed to the Settlement Class Members who
timely submitted their Notices of Intent to Submit Claim Form. If you receive a Supplemental Payment check,
you must cash the check within 6 months after it is issued or it will become void.
To Correct Inaccurate Information about Your Employment at Alcon: Section 3 of this Notice contains
information that Alcon provided about your employment. This includes the job titles in the Settlement Classes
that you held from March 17, 2012 through November 12, 2015, the dates when you held each job title from
March 17, 2012 through November 12, 2015, the Class to which each job title corresponds, and the compensation
you received from March 17, 2012 through November 12, 2015. If you believe that any of the information
provided by Alcon is inaccurate, you must submit a written challenge and provide any available supporting
documentation showing that the information contained in Alcon’s records should be corrected and that corrected
information should be used. Your written challenge and supporting documentation must be mailed to the Claims
Administrator with a postmark of no later than [30 days after Notice is mailed].
To Exclude Yourself from the Settlement: If you want to exclude yourself from this Settlement, you must
send the Claims Administrator an opt-out statement requesting exclusion with a postmark of no later than [30
days after Notice is mailed]. The request for exclusion must contain the statement, “I request exclusion from
the class settlement in Orr et al. v. Novartis Corporation and Alcon Laboratories, Inc.” The request for
exclusion must be signed by the Settlement Class Member who seeks to opt out and must contain the Settlement
Class Member’s name, address, and telephone number. If you exclude yourself from this Settlement, you will
not be eligible to receive any money, you will not be bound by this Settlement, and you cannot object to the
Settlement.
To Object to the Settlement: If you want to object to the Settlement, you must send your objection in
writing, with a postmark of no later than [30 days after Notice is mailed], to the Claims Administrator. Any
objection must contain the statement, “I object to the class settlement in Orr et al. v. Novartis Corporation and
Alcon Laboratories, Inc.,” must include a detailed description of the basis for the objection, must be signed by
the Settlement Class Member who is objecting, and must contain the Settlement Class Member’s name, address,
and telephone number. Settlement Class Members who fail to make objections in the manner specified above
will be deemed to have waived any objections and will be foreclosed from making any objection (whether by
appeal or otherwise) to the Settlement Agreement. If the Court rejects your objection, you will still be bound
by the terms of the Settlement.
For each of the foregoing deadlines, the postmark date of the mailing envelope that you send will be the exclusive
method used to determine whether you satisfied the deadline.
Case 1:15-cv-01980-GHW Document 94-1 Filed 08/02/16 Page 15 of 24
Page 6 of 8
6. How Will My Settlement Award Be Calculated?
Each Settlement Class Member will receive a Base Payment of at least $50. The Base Payment will be calculated
for each Settlement Class Member based on what job position(s) she held from March 17, 2012 through
November 12, 2015 (the “eligibility period”), the Settlement Class(es) to which the job position(s) correspond,
the total compensation (regular earnings, short-term incentive compensation, and long-term incentive
compensation) that she received during the time she was employed from March 17, 2012 through November 12,
2015 as a member of the Settlement Class(es), and the gender coefficient(s) for the Settlement Class(es) to which
her job position(s) correspond (according to a statistical model developed by Plaintiffs’ expert).
In order to illustrate how Base Payments are calculated, the following sample calculations show what several
hypothetical Settlement Class Members may expect to receive as Base Payments. (These are only estimates;
actual payments may vary depending on, among other things, the level of participation by other class and
collective action members in the Settlement.)
If a Director Class Member worked for 2 years during the eligibility period and earned total
compensation during this time at the annual rate of $267,486, her Base Payment is estimated at $4,896.
If a Manager Class Member worked for 3 years during the eligibility period and and earned total
compensation during this time at the annual rate of $181,949, her Base Payment is estimated at $3,681.
If a Specialist/Analyst Class Member worked for 1 year during the eligibility period and earned total
compensation during this time at the annual rate of $120,818, her Base Payment is estimated at $1,192.
If a Sales Class Member worked for 3 years during the eligibility period and earned total compensation
during this time at the annual rate of $91,377, her Base Payment is estimated at $466.
In addition, each Settlement Class Member who submits a timely, complete, and responsive Notice of Intent to
Submit Claim Form, as well as a timely, complete, and responsive Claim Form, alleging that at any time from
March 17, 2012 through November 12, 2015, she was discriminated against on account of her gender in
promotion or in assignment to a job, compensation grade, or compensation band, will be eligible to receive a
Supplemental Payment.
7. How Will My Settlement Award Be Reported for Tax Purposes?
For tax purposes, 50% of each Base Payment and each Supplemental Payment will be reported as wage payments
on a Form W-2 and will be subject to the withholding of required payroll taxes. The remaining 50% of each
Base Payment and each Supplemental Payment will be reported as non-wage income for non-wage damages on
a Form 1099.
Neither Class Counsel nor Defendants make any representations concerning the tax consequences of this
Settlement, and Settlement Class Members are advised to seek their own personal tax advice in connection with
the settlement payments.
8. What Claims Am I Releasing as Part of This Settlement?
If the Court grants final approval of the Settlement, then all Settlement Class Members who do not exclude
themselves from the Settlement will release any and all past or present claims of gender-based employment
discrimination in pay, promotion, and assignments while employed at Alcon from March 12, 2012, through
[Preliminary Approval Date] arising out of the same transactions, series of connected transactions, occurrences,
or nucleus of operative facts that form the basis of the claims asserted in the Civil Action on behalf of Settlement
Class Members (including in the original and amended complaint) (“Class Claims”). This includes claims of
gender-based employment discrimination in pay, promotion, and assignments brought under Title VII of the
Civil Rights Act of 1964, as amended, 42 U.S.C. §§ 2000e, et seq. (“Title VII”), the Equal Pay Act of 1963, 29
Case 1:15-cv-01980-GHW Document 94-1 Filed 08/02/16 Page 16 of 24
Page 7 of 8
U.S.C. § 206(d) (the “Equal Pay Act”), and any other federal, state, or local statutes, common law, or regulation
prohibiting gender-based employment discrimination in pay, promotion, and assignments.
Settlement Class Members who do not exclude themselves from the Settlement but fail to cash a settlement
check or otherwise opt-in to an Equal Pay Act Collective in this case will release all claims described in the
above paragraph other than those brought under the Equal Pay Act. However, unless you exclude yourself from
the Settlement, you will release the other claims affected by the Settlement regardless of whether you cash your
settlement check.
When you “release” a claim, it means you cannot sue Defendants for the same claims that are covered by the
Civil Action, as set forth in the Settlement Agreement. The terms of the release are set forth in Section 10 of
the Settlement Agreement.
You retain your right to sue on any claims that are not released as part of this Settlement. By participating in
this Settlement, Settlement Class Members do not release any claims for sexual harassment, hostile work
environment, retaliation, constructive discharge, wrongful termination, or any other discrimination in the terms
and conditions of employment that any Settlement Class Member may have under Title VII and/or any other
federal, state, or local statutes, common law, or regulations (other than the claims of gender-based employment
discrimination in pay, promotion or assignments described in the paragraphs above).
9. Do I Have a Lawyer in This Case?
The law firm of Sanford Heisler, LLP has been designated as legal counsel to represent you and the other
Settlement Class Members. You will not be charged separately for these lawyers; their fees and expenses will
be paid from the Total Settlement Amount in an amount awarded by the Court only if and after the Settlement
has been approved by the Court. If you want to be represented by your own lawyer, you may hire one at your
own expense.
10. How Will The Lawyers Be Paid?
Class Counsel took this case on a contingency basis; in other words, the lawyers agreed that they would only be
compensated for their work if they obtained a recovery for the Class Members.
As is routine in class action and collective action cases, Class Counsel will request an award of attorneys’ fees
and expenses incurred in connection with the class action and collective action in the Civil Action and this
Settlement. Class Counsel will request that the Court award them attorneys’ fees not exceeding one-third of the
Total Settlement Amount. This will pay Class Counsel for all work that they have performed and will continue
to perform in this action, including investigating and analyzing the facts, participating in private mediation, and
negotiating and overseeing the Settlement. In addition, Class Counsel will request reimbursement of costs that
Class Counsel incurs (which are estimated to total $175,000, including all costs for the Claims Administrator
and all costs for Plaintiffs’ expert).
11. Will Certain Plaintiffs Receive Any Additional Award for Bringing and Litigating This Case on
Behalf of the Settlement Class Members?
Class Counsel will ask the Court to approve service payments of up to between $5,000 and $20,000 to each of
the Class Representatives and Collective Action Representatives. These payments will come from the Total
Settlement Amount and will total no more than $110,000. Class Counsel will seek these payments as service
awards to compensate the Class Representatives and Collective Action Representatives for their service in
pursuing the class action and collective action claims in this case on behalf of Settlement Class Members and in
bringing about this Settlement.
Case 1:15-cv-01980-GHW Document 94-1 Filed 08/02/16 Page 17 of 24
Page 8 of 8
12. When and Where Will The Court Decide Whether to Approve the Settlement?
Every class action must be approved by the court that presided over the lawsuit. The Court will hold a final
settlement fairness hearing on [DATE] at [TIME] in Courtroom 12C, 500 Pearl Street, New York, NY 10007.
The case is assigned to the Honorable Gregory H. Woods, United States District Court Judge for the United
States District Court for the Southern District of New York. You may, but are not required to, attend.
At this hearing the Court will consider whether the terms of the Settlement are fair, reasonable, and adequate.
If there are written objections, the Court will consider them. You are not required to appear at the hearing;
however if you wish to speak at the hearing, you must have previously submitted your written objection
according to the directions outlined in Section 5 above. The Court will listen to people who have asked to speak
at the hearing. The Court may also decide how much to award to Class Counsel and to the proposed recipients
of service payments. Following the hearing, the Court will decide whether to approve the Settlement.
13. How Can I Find Out More Information about the Settlement?
This Notice contains only a summary of the terms of the Settlement. The complete terms of the Settlement are
in the Class and Collective Settlement Agreement and Release and the First Amendment to the Class and
Collective Settlement Agreement and Release (collectively, “Settlement Agreement”). You may obtain a copy
of the Settlement Agreement, and additional information pertaining to the Settlement, by contacting Class
Counsel or the Claims Administrator using the contact information below or by visiting their websites listed
below. You may also view the Settlement Agreement in hard copy at the Office of the Clerk, United States
District Court for the Southern District of New York, 500 Pearl Street, New York, New York 10007.
If you have further questions about the Settlement or are still not sure whether you are included, you can get free
help by contacting Class Counsel or the Claims Administrator as follows:
Class Counsel: David Sanford, Esq.
Sanford Heisler, LLP
1350 Avenue of the Americas, 31st Floor
New York, NY 10019
Phone: 646-402-5650
Fax: 646-402-5651
Website: www.sanfordheisler.com
Claims Administrator: Orr v. Novartis Claims Administrator
Kurtzman Carson Consultants LLC P.O. Box 40007
College Station, TX 77842-4007
Phone: XXX-XXX-XXXX
Fax: XXX-XXX-XXXX
Website: www.XXXX.com
PLEASE DO NOT CALL OR CONTACT THE COURT, THE OFFICE OF THE CLERK OF COURT,
OR DEFENDANTS WITH QUESTIONS REGARDING THIS NOTICE.
Case 1:15-cv-01980-GHW Document 94-1 Filed 08/02/16 Page 18 of 24
Page 1 of 1
Orr v. Novartis Claims Administrator
Kurtzman Carson Consultants LLC
P.O. Box 40007
College Station, TX 77842-4007
IMPORTANT LEGAL MATERIALS
<<First Name>> <<Middle Name>> <<Last Name>>
<<Address>>
<<City>>, <<State>> <<Zip>>
Full Name: _____________________________________________
Address: ______________________________________________
City: __________________________________________________
State: ____________________ Zip Code:____________________
If the pre-printed information to the left is not correct or if
there is no pre-printed information, please check the box
and complete the information below:
NOTICE OF INTENT TO SUBMIT CLAIM FORM
ORR, ET AL. v. NOVARTIS CORPORATION AND ALCON LABORATORIES, INC.
Your Notice of Intent to Submit Claim Form must be returned POSTMARKED by no later than [30
DAYS AFTER NOTICE IS MAILED]. Enclosed is an envelope, with postage pre-paid, for returning
your Notice of Intent to Submit Claim Form.
Settlement Class Members who allege that, at any time from March 17, 2012, through November 12, 2015,
they were discriminated against based on their gender in seeking a promotion or in assignment to a job,
compensation grade, and/or compensation band may be eligible to receive a Supplemental Payment if they
take certain affirmative steps, which are summarized in Section 5 of the attached Notice of Pendency of
Proposed Class Action and Collective Action Settlement.
If you seek to receive a Supplemental Payment, as a first step you must complete this Notice of Intent to
Submit Claim Form and send it to the Claims Administrator (Orr v. Novartis Claims Administrator,
Kurtzman Carson Consultants LLC, P.O. Box 40007, College Station, TX 77842-4007) with a postmark
of no later than [30 days after Notice is mailed]. If you answer “No” to Question #1 below, you are not
eligible to receive a Supplemental Payment and should not submit this Notice of Intent to Submit Claim Form.
Additional steps will be required after the Court grants final approval of the Settlement; these steps and the
applicable deadlines will be described in a mailing to those Settlement Class Members who timely complete
this Notice of Intent to Submit Claim Form. The mailing will be sent after the Court grants final approval of
the Settlement.
* * *
1. Do you believe that, at any time from March 17, 2012 through November 12, 2015, (1) you were
discriminatorily denied a promotion based on your gender, or (2) you were discriminated against based
on your gender in an assignment to a job, compensation grade, or compensation band?
Yes No
_____________________________________ _____________________________________
Signature of Claimant Personal Email Address of Claimant
_____________________________________ _____________________________________
Typed or Printed Name of Claimant Preferred Phone Number for Claimant
Case 1:15-cv-01980-GHW Document 94-1 Filed 08/02/16 Page 19 of 24
Exhibit C
Case 1:15-cv-01980-GHW Document 94-1 Filed 08/02/16 Page 20 of 24
Page 1 of 4
Orr v. Novartis Claims Administrator
Kurtzman Carson Consultants LLC
P.O. Box 40007
College Station, TX 77842-4007
IMPORTANT LEGAL MATERIALS
<<First Name>> <<Middle Name>> <<Last Name>>
<<Address>>
<<City>>, <<State>> <<Zip>>
Full Name:____________________________________________________
Address: ____________________________________________________
City: ________________________________________________________
State: ____________________ Zip Code: __________________________
If the pre-printed information to the left is not correct or if
there is no pre-printed information, please check the box and
complete the information below:
CONFIDENTIAL CLAIM FORM FOR SUPPLEMENTAL PAYMENT
ORR, ET AL. v. NOVARTIS CORPORATION AND ALCON LABORATORIES, INC.
Your Claim Form must be returned POSTMARKED by no later than [60 DAYS AFTER EFFECTIVE DATE].
Enclosed is an envelope, with postage pre-paid, for returning your Claim Form.
You are receiving this Claim Form because our records indicate that you submitted a timely, complete, and responsive
Notice of Intent to Submit Claim Form. If you follow the instructions in this Claim Form, you may be eligible to receive a
Supplemental Payment as part of the monetary settlement in this case.
You do not have to submit this Claim Form in order to receive a portion of the monetary settlement. If you are the
intended recipient of this Claim Form, you will automatically receive a Base Payment from this settlement, as explained
in the Notice previously sent to you on [DATE ORIGINAL NOTICE WAS SENT]. You do not need to do anything to
receive your Base Payment, which will be placed in the mail by [60 DAYS AFTER EFFECTIVE DATE].
However, in addition, you may be eligible to receive a Supplemental Payment if, during the period from March 17, 2012,
to November 12, 2015, you believe that you experienced gender discrimination in seeking a promotion and/or in
assignment to a job, compensation grade, and/or compensation band. In order to receive a Supplemental Payment, you
must submit timely, complete, and responsive answers to every question in this Claim Form and must do so under
penalty of perjury.
Based on the answers you provide in your completed Claim Form, the Claims Administrator will determine if you are
eligible to receive a Supplemental Payment. The decision of the Claims Administrator will be final. If you are
determined to be eligible, you will be awarded a Supplemental Payment based on the total compensation (regular
earnings, short-term incentive compensation, and long-term incentive compensation) that you received following the
event of alleged discrimination, the Settlement Class(es) of which you were a member following the event of the alleged
discrimination, and the gender coefficient(s) corresponding to those Settlement Class(es) (according to a statistical model
developed by Plaintiffs’ expert).
INSTRUCTIONS
1. Answer all questions on pages 2 and 3 of this Claim Form. If you answer “No” to #7, you are not eligible to
receive a Supplemental Payment and should not submit a Claim Form and/or a Declaration.
2. Sign and date the Declaration on page 4 of the Claim Form.
3. Mail your completed Claim Form and Declaration to the Claims Administrator at the address listed on page 4 of the
Claim Form, postmarked on or before [60 DAYS AFTER EFFECTIVE DATE]:
4. That’s it! All supplemental payments will be mailed by [240 DAYS AFTER EFFECTIVE DATE].
NEED ASSISTANCE? If you need assistance in completing your Claim Form, you can get free help by contacting
Class Counsel: Sanford Heisler, LLP, 1350 Avenue of the Americas, 31st Floor, New York, NY 10019, Tel: (646)
402-5650, Fax: (646) 402-5651, www.sanfordheisler.com. You can also get free help by contacting the Claims
Administrator: Kurtzman Carson Consultants LLC, P.O. Box 40007, College Station, TX 77842-4007, Tel: (XXX)
XXX-XXXX, Fax: (XXX) XXX-XXXX, www.XXXX.com.
Case 1:15-cv-01980-GHW Document 94-1 Filed 08/02/16 Page 21 of 24
Page 2 of 4
All information contained in this Claim Form will be kept strictly CONFIDENTIAL. Your answers will only be used in
order to administer Supplemental Payments. The fact that you submitted a Claim Form and the answers you provided will
NOT be disclosed to Alcon Laboratories, Inc. or Novartis Corporation.
1. Full Name: ________________________________________________________________________ Last First Middle
2. Home Telephone Number: ( ____ ____ ____ ) ____ ____ ____ - ____ ____ ____ ____
3. Cell Telephone Number: ( ____ ____ ____ ) ____ ____ ____ - ____ ____ ____ ____
4. Personal E-Mail Address: ____________________________________________________
5. Social Security Number: ____ ____ ____ - ____ ____ - ____ ____ ____ ____
6. Date of Birth: ________ / ________ / ______________
7. Do you believe that, at any time from March 17, 2012 through November 12, 2015, (1) you were discriminatorily
denied a promotion based on your gender, or (2) you were discriminated against based on your gender in an
assignment to a job, compensation grade, or compensation band?
Yes No
If you answered “Yes” to #7, please answer #8-10 below. If you answered “No” to #7, you are not eligible to
receive a Supplemental Payment and should not submit a Claim Form.
8. Please provide in the lines below or as an attachment to this Claim Form a brief written explanation regarding the
basis for your belief that during the period from March 17, 2012 through November 12, 2015, (1) you were
discriminatorily denied a promotion based on your gender, or (2) you were discriminated against based on your
gender in an assignment to a job, compensation grade, or compensation band. Please note that your answer to this
question will be used to determine whether or not you are eligible for a Supplemental Payment.
(Relevant information regarding a claim of discrimination in promotion may include: the name of the position that
you believe you were discriminatorily denied, your qualifications for the position, the date and method by which you
applied for the position, the name of the male applicant who received the position, and any other circumstances
suggesting that you were denied the position because of your gender. Relevant information regarding a claim of
discrimination in an assignment to a job, compensation grade, or compensation band may include: the job,
compensation grade, or compensation band to which you believe you were discriminatorily assigned; the date and
method by which you believe you were discriminatorily assigned; your qualifications for a better job, compensation
grade, or compensation band; the name of any male employees who were similarly qualified as you but were
assigned to a better job, compensation grade, or compensation band; and any other circumstances suggesting that you
were assigned to an inferior job, compensation grade, or compensation band because of your gender.)
______________________________________________________________________________________________
______________________________________________________________________________________________
______________________________________________________________________________________________
______________________________________________________________________________________________
______________________________________________________________________________________________
______________________________________________________________________________________________
______________________________________________________________________________________________
______________________________________________________________________________________________
______________________________________________________________________________________________
Case 1:15-cv-01980-GHW Document 94-1 Filed 08/02/16 Page 22 of 24
Page 3 of 4
______________________________________________________________________________________________
______________________________________________________________________________________________
______________________________________________________________________________________________
______________________________________________________________________________________________
______________________________________________________________________________________________
______________________________________________________________________________________________
______________________________________________________________________________________________
______________________________________________________________________________________________
______________________________________________________________________________________________
______________________________________________________________________________________________
______________________________________________________________________________________________
______________________________________________________________________________________________
______________________________________________________________________________________________
______________________________________________________________________________________________
______________________________________________________________________________________________
______________________________________________________________________________________________
______________________________________________________________________________________________
9. What is the approximate date (month, day, and year) when you believe you first experienced the discrimination in
promotions or assignments that you allege in your responses to Questions 7 and 8? Please note that your answer to
this question will be used in computing the amount of your Supplemental Payment.
(For a promotion claim, this may be the date when you first learned that you were denied the promotion or the date
when another applicant was selected for the promotion, whichever occurred first. For an assignment claim, this may
be the date when you were first assigned to the lower job, compensation grade, or compensation band.)
______________________________________________________________________________________________
10. Please provide in the lines below or as an attachment to this Claim Form a brief written explanation regarding the
basis for the date you supplied in your answer to Question 9.
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
_____________________________________________________________________________________________
Case 1:15-cv-01980-GHW Document 94-1 Filed 08/02/16 Page 23 of 24
Page 4 of 4
DECLARATION
I, ___________________________________, DECLARE UNDER PENALTY OF PERJURY THAT THE
INFORMATION AND FACTS I HAVE STATED IN THIS CLAIM FORM ARE TRUE AND
CORRECT TO THE BEST OF MY KNOWLEDGE.
I understand that I must keep the Claims Administrator informed of my home address and of any change
in my home address. If I do not do so, I understand that I may not receive any award that I might
otherwise be entitled to receive.
Executed this _______ day of ________________________, 2016.
_____________________________________
Signature of Claimant
_____________________________________
Typed or Printed Name of Claimant
To be eligible, your completed Claim Form and signed Declaration must be postmarked by [60 DAYS
AFTER EFFECTIVE DATE]. You should NOT submit a Claim Form and/or Declaration if you answered
“No” to #7 in this Claim Form.
All Claim Form submissions should be mailed to:
Orr v. Novartis Claims Administrator
Kurtzman Carson Consultants LLC
P.O. Box 40007
College Station, TX 77842-4007
Case 1:15-cv-01980-GHW Document 94-1 Filed 08/02/16 Page 24 of 24